Skip to main content
. 2017 Feb 7;18:15. doi: 10.1186/s12875-017-0588-2

Table 2.

Patients’ safety-relevant knowledge of OAT: Proportion of patients giving correct answers (at a single-item level)a

Item no. Item Intervention group Control group
Baseline After 12 mo. After 24 mo. Baseline After 12 mo. After 24 mo.
1 Indication for oral anticoagulation 60.0% 61.3% 60.8% 60.9% 57.3% 55.7%
2 Awareness of risk treated with OAT 67.7% 67.9% 65.4% 70.6% 67.4% 64.9%
3 Duration of treatment known 70.7% 74.9% 76.8% 68.7% 69.1% 68.6%
4 Checking frequencies known 37.8% 46.5% 44.0% 36.7% 42.4% 41.2%
5 Target INR range known 37.8% 59.5% 56.9% 36.1% 45.5% 43.7%
6 Foods which contain a large amount of vitamin K 29.0% 34.1% 31.6% 30.2% 29.2% 25.3%
7 Diet-related recommendations 70.7% 68.2% 69.3% 65.5% 67.4% 66.8%
8 Safest analgesic that is available without a prescription 11.0% 25.1% 26.8% 12.7% 15.4% 13.8%
9 What to do after missing medication dose 19.5% 28.6% 30.1% 16.4% 19.9% 16.3%
10 Awareness that underdosing results in no symptoms 14.5% 15.6% 15.7% 13.7% 14.6% 10.2%
11 Interactions with OAT 20.0% 26.9% 28.3% 19.4% 22.8% 20.3%
12 Recognition of emergencies (doctor’s visit necessary) 6.3% 22.5% 16.3% 6.7% 5.9% 6.8%
13 Knowing when it is important to inform others of OAT 26.0% 35.0% 30.4% 27.8% 23.9% 19.1%

aAnalyses are based on 736 patients at baseline, 702 after 12 months and 657 patients after 24 months. 12 and 24-month follow-up data for the secondary endpoint patient knowledge were available for all patients who did not drop out. After 24 months, 79 patients (10.7%) dropped out because of death or the patient’s decision to no longer participate